John Wiley & Sons Inc. has entered a strategic partnership with OpenEvidence to integrate Wiley’s peer-reviewed scientific and medical content into the OpenEvidence medical AI platform. The deal will license a broad portfolio including the Cochrane Database of Systematic Reviews, Cochrane Clinical Answers, and more than 400 Wiley journals and books, giving physicians source-cited evidence to support point-of-care clinical decisions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. John Wiley & Sons Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260303408088) on March 03, 2026, and is solely responsible for the information contained therein.